Retinol, the reference renewal active

Retinol remains the most validated renewal active in dermocosmetics: it accelerates epidermal turnover, supports collagen production and refines texture, with decades of evidence behind it. In a professional context, the questions are not whether retinol works, but in which form, at which concentration, and how to schedule it around in-clinic procedures.

Professional use: form and timing

• Pure stabilised retinol – RETINOL 1.0 delivers pure stabilised retinol in an airless system that keeps over 80% of the retinol active after 12 months – stability being the real differentiator between professional and mass-market retinol.
• Low-dose retinol in regenerative complexes – SKIN BOOSTER CREAM integrates a low-dose retinol alongside PDRN and exosomes for daily use.
• Retinyl palmitate – the gentler retinoid ester, used in the F-RADIANCE and F-VITAMIN ACE sterile vials.
• Timing around procedures – retinol is typically paused briefly before and after aggressive treatments (peels, laser, micro-needling), then reintroduced to consolidate results – always under practitioner guidance.
• Tolerance pairing – retinol combines well with niacinamide, and ectoin is documented to reduce retinol-induced irritation, allowing stronger routines.

Fusion Meso formulations with retinol

• RETINOL 1.0 – pure stabilised retinol, airless system, for photo-ageing and acne-prone skin.
• SKIN BOOSTER CREAM – low-dose retinol in a regenerative complex with PDRN and exosomes.
• F-RADIANCE – retinyl palmitate in the pigmentation sterile-vial protocol.
• ACN CORRECTOR – the acne-focused corrective companion in retinol renewal routines.

Frequently asked questions

Can patients use retinol during a mesotherapy programme?

Usually yes, with a short pause around each session as advised by the practitioner. The renewal and regeneration mechanisms are complementary.

Why stability matters more than percentages?

Stabilised, airless-protected retinol that stays active outperforms higher concentrations that have degraded – and keeps tolerance manageable in protocols that already include in-clinic procedures.